Literature DB >> 5497895

Inhibition of Poxvirus replication by streptovaricin.

N A Quintrell, B R McAuslan.   

Abstract

A component of streptovaricin complex inhibits the replication of poxvirus. To be effective, the inhibitor must be introduced early in the replication cycle; it appears to inhibit early messenger ribonucleic acid synthesis by viral cores, thus interfering with all subsequent events. Neither of the two major components of the complex, streptovaricin A or C, was the active component.

Mesh：

Substances：

Year:  1970        PMID： 5497895      PMCID： PMC376147     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  11 in total

1.  The purification of vaccinia virus from cell cultures.

Authors:  D N PLANTEROSE; C NISHIMURA; N P SALZMAN
Journal:  Virology       Date:  1962-10       Impact factor: 3.616

2.  Messenger RNA synthesis by a "coated" viral genome.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-02       Impact factor: 11.205

3.  Inhibition of DNA-dependent RNA polymerase reaction of Escherichia coli by an antimicrobial antibiotic, streptovaricin.

Authors:  S Mizuno; H Yamazaki; K Nitta; H Umezawa
Journal:  Biochim Biophys Acta       Date:  1968-04-22

4.  Rifampicin inhibition of vaccinia replication.

Authors:  B R Mcauslan
Journal:  Biochem Biophys Res Commun       Date:  1969-10-08       Impact factor: 3.575

5.  Rifampicin: a specific inhibitor of vaccinia virus assembly.

Authors:  B Moss; E N Rosenblum; E Katz; P M Grimley
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

6.  Induction of poxvirus ribonucleic acid polymerases.

Authors:  A Pitkanen; B McAuslan; J Hedgpeth; B Woodson
Journal:  J Virol       Date:  1968-12       Impact factor: 5.103

7.  Rifampicin and poxvirus replication.

Authors:  Z Ben-Ishai; E Heller; N Goldblum; Y Becker
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

8.  Poxvirus DNA-dependent RNA polymerase.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

9.  Vaccinia virus directed RNA and protein synthesis in the presence of rifampicin.

Authors:  B Moss; E Katz; E N Rosenblum
Journal:  Biochem Biophys Res Commun       Date:  1969-08-22       Impact factor: 3.575

10.  Induction of cytoplasmic ribonucleic acid (RNA) synthesis in vaccinia-infected LM cells during inhibition of protein synthesis.

Authors:  W H Munyon; S Kit
Journal:  Virology       Date:  1966-06       Impact factor: 3.616
View more
  7 in total

1.  Antivirion effects of streptovaricin complex against Friend virus.

Authors:  J S Horoszewicz; S S Leong; D M Byrd; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

2.  Activity of pure streptovaricins and fractionated streptovaricin complex against Friend virus.

Authors:  J S Horoszewicz; K L Rinehart; S S Leong; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Inhibition of poxvirus maturation by rifamycin derivatives and related compounds.

Authors:  T H Pennington; E A Follett
Journal:  J Virol       Date:  1971-06       Impact factor: 5.103

4.  Responses of the murine myeloid colony-forming cell to ansamycin antibiotics.

Authors:  J S Horoszewicz; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

Review 5.  Actions of the rifamycins.

Authors:  W Wehrli; M Staehelin
Journal:  Bacteriol Rev       Date:  1971-09

6.  Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles.

Authors:  J F Szilágyi; T H Pennington
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

7.  Mechanism of antiviral action of acetone on rabbitpox virus replication.

Authors:  V I Chernos; B A Libshits; E Yakobson; Y Z Ghendon
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.